Innovative artificial intelligence startups aim to cure loss of vision – The South African

Original article can be found here (source): artificial intelligence

According to a study conducted by one of the world’s leading market research firms, the AI market for healthcare applications will likely see a rise from 663.8m to 6 662m, a tenfold growth between the years 2014 and 2021.

However, there has also been a rising disparity between the existing AI-based healthcare solutions and the current healthcare demands. 

In fact, startups such as NovaSight and Artelus are making strides through their relevant, in demand, and well-thought applications of AI to address such types of eye disorders.

Innovation in the realm of eye-care

With more than 50% of our sensory perception solely reliant on eyes, it is essential to recognize the importance and influence of prompt eye-care in our current times.

Combined with the fact that most smartphone users spend more than three hours a day staring at a screen, the urgency of eye-health is now greater than ever. 

The current protocol to treating this condition would be approaching an eye doctor and undergoing the eye-drop therapy, which blurs the vision in the functional eye to force the brain to rely on the faulty eye as well.

It is also worth noting that unsuccessful treatment of this condition in childhood will result in the continued loss of vision in adulthood as well. 

Addressing the urgent eye-care needs

NovaSight, a startup, is guided by the mission to “bring pediatric vision care into the digital age”. The company has now brought a cutting-edge digitised solution towards Amblyopia (lazy eye) treatment.

Unlike the conventional treatment involving an eye-patch and eye-drop-therapy, NovaSight has developed CureSight, an AI-based eye-tracking solution. 

How does it work? Well, the technology in the glasses “tracks the eye movement and blurs the stronger eye“. This then gradually forces the brain to rely on the weaker amblyopic eye.

Developing learning systems based on AI

Compared to the uncomfortable and limiting eye-patch treatment, asking children to watch the content they enjoy while improving their eyesight is the perfect amalgamation of comfort, accessibility, and prompt healthcare. 

“The system is leased to patients for the duration of the treatment, which usually runs on average from three to four months. CureSight contains dozens of video content sources like Netflix, Amazon Prime, Disney Channel, and more”.

Mosche Barel, NovaSight’s VP for sales and marketing

While NovaSight is steadily advancing the amblyopia treatment, another Indian startup known as Artelus is focused on assisting healthcare professionals to fight the diabetics-induced loss of vision. 

The Artelus team developed a learning system based on AI and deep learning which mic is the human brain’s neural systems. Because it utilises AI, the system learns continuously and ‘perfects itself’.

As of now, the Indian startup’s computer-aided screening empowers any eye doctor to detect the early onset of diabetic retinopathy to prevent the loss of vision. 

Information sourced from SparkAmplify Lab’s startup guides.

DMCA.com Protection Status